A small interfering RNA targeting the KLF6 splice variant, KLF6-SV1, as gene therapy for gastric cancer

KLF6-SV1 Is a Novel Antiapoptotic Protein That Targets the BH3-Only Protein NOXA for Degradation and Whose Inhibition Extends Survival in an Ovarian Cancer Model

(2009) A. DiFeo et al.   CANCER RESEARCH

Treatment of collagen‐induced arthritis with an anti‐osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells

(2008) Kexing Fan et al.   ARTHRITIS AND RHEUMATISM

Transforming Growth Factor   Induces Apoptosis through Repressing the Phosphoinositide 3-Kinase/AKT/Survivin Pathway in Colon Cancer Cells

(2008) J. Wang et al.   CANCER RESEARCH

A Functional Role for KLF6-SV1 in Lung Adenocarcinoma Prognosis and Chemotherapy Response

(2008) A. DiFeo et al.   CANCER RESEARCH

The role of KLF6 and its splice variants in cancer therapy

(2008) Analisa DiFeo et al.   DRUG RESISTANCE UPDATES

Increased alternative splicing of the KLF6 tumour suppressor gene correlates with prognosis and tumour grade in patients with pancreatic cancer

(2008) Mark Hartel et al.   EUROPEAN JOURNAL OF CANCER

Functional role of the KLF6 tumour suppressor gene in gastric cancer

(2008) Jaya Sangodkar et al.   EUROPEAN JOURNAL OF CANCER

KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis

(2008) Goutham Narla et al.   JOURNAL OF CLINICAL INVESTIGATION

Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates

(2008) M. Frank-Kamenetsky et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA